Q1 2024 · 13F-HR
CAXTON CORPholdings as filed
Filed 2024-05-15 · accession 0000919574-24-003094
$17.6M
Reported value
11
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $11.3M | 64.4% | 5,113,348 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $3.4M | 19.2% | 1,318,967 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $970,988 | 5.53% | 1,856 | Common | SOLE |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $428,308 | 2.44% | 1,019 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $393,614 | 2.24% | 15,846 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $306,580 | 1.75% | 136,866 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $273,207 | 1.56% | 29,065 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $226,055 | 1.29% | 15,808 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $161,796 | 0.92% | 10,319 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $86,062 | 0.49% | 43,465 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $41,096 | 0.23% | 17,488 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.